2019 Jul;120(7):11921-11930
Potential adverse effects, such as mucocutaneous dryness, lipid and liver changes, and teratogenicity, must also be taken into account
To help hydrate and support your recovery
As the wellness industry moves away from quick fixes and embraces holistic approaches, FuturHealth is at the forefront of this transformation
Crizanlizumab is a monoclonal antibody to P-selectin and its mechanism of action is to block the adhesion of activated erythrocytes, neutrophils and platelets
In the early phase, MA elevated LC3-positive cells, LC3-I to LC3-II conversion, and proliferation of the beclin1 molecule and reduced the expression of the autophagy substrate p62 in rat neurons after TBI